Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLN-177 in recurrent calcium oxalate kidney stone formers with hyperoxaluria
NCT02289755Phase 2Completed
- Sponsor
- Allena Pharmaceuticals, Inc.
- Start
- Sep 2014
- Primary completion
- Jan 2015
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of reloxaliase in hyperoxaluria, nephrolithiasis, sponsored by Allena Pharmaceuticals, Inc.. Started Sep 2014; status: completed.
02
Drugs
reloxaliase
03
Conditions
hyperoxalurianephrolithiasis
Beyond the preview
Go deeper on NCT02289755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289755.